Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TCF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MRPL17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLIC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POLR2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CKAP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GALT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APLP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSR4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SYNE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRPF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRDX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD2BP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPHB6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STYXL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCRN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KDM4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ST13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CREB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MMP15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on